A secondary analysis of the SOUL trial shows significant improvement in heart failure outcomes with oral semaglutide vs placebo, consistent with the injectable formulation.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/soul-oral-semaglutide-benefits-extend-heart-failure-2026a10006z4?src=rss
Author :
Publish date : 2026-03-06 12:39:00
Copyright for syndicated content belongs to the linked Source.
